Waiting for other shoes to drop

Uncertainty continued to hover over the cluster of companies that once huddled under the financial umbrella of New York financier David Blech, with Bio-Technology General Corp.'s R&D spinoff today waiting to close a $3.75 million tranche from a Blech-placed funding.

The BTGC situation follows on MicroProbe Corp.'s announcement last week that Blech would be unable to provide further funds to the company, jeopardizing MPRO's ability to continue operations...